FamilieSCN2A Foundation Partners with NORD® to Initiate Registry for SCN2A-related disorders
Global research study plans to accelerate treatments for SCN2A-related disorders, a rare disease associated with epilepsy, intellectual disability, and autism. GETTYSBURG, PA, UNITED STATES, March 7, 2024 /EINPresswire.com/ -- The FamilieSCN2A …